Our data first revealed increased PIWIL1 levels in MM patients and MM cell lines, and high PIWIL1 expression was linked to advanced disease stage and refractoriness/relapse, suggesting that aberrantly expressed PIWIL1 can be employed as a new class of diagnostic and prognostic biomarker during MM development. The gene discussed is PIWIL1; the disease is Miyoshi myopathy.